Index by author

September 01, 2019; Volume 86,Issue 9

  1. Makin, Vinni

    1. Diabetes management: Beyond hemoglobin A1c
      Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
      Cleveland Clinic Journal of Medicine September 2019, 86 (9) 595-600; DOI: https://doi.org/10.3949/ccjm.86a.18031

      Other factors include cardiovascular benefit, weight control, hypoglycemia risk, and cost.

  2. Mandell, Brian F.

    1. Clinical outcomes in diabetes: It’s not just the glucose (and it’s not so simple)
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine September 2019, 86 (9) 573-574; DOI: https://doi.org/10.3949/ccjm.86b.09019

      As we dig deeper into the reduction in cardiovascular deaths seen with some newer drugs, several questions arise.

  3. Momoniat, Tasnim

    1. ACE inhibitors and ARBs: Managing potassium and renal function
      Tasnim Momoniat, MBCHB, MRCP (UK), Duha Ilyas, MBBS, MRCP (UK) and Sunil Bhandari, MBCHB, FRCP, PhD, M CLIN EDU, FHEA
      Cleveland Clinic Journal of Medicine September 2019, 86 (9) 601-607; DOI: https://doi.org/10.3949/ccjm.86a.18024

      Concern about hyperkalemia and a decline in renal function has led to underuse of these drugs.

Back to top

In this issue